## Note
nid: 1578183592464
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_2::Cheesy_Dorian_(M3), #AK_Step2_v11::!Shelf::#Cards_AnKing_Did::4fm, #AK_Step2_v11::!Shelf::FM::no_dupes, #AK_Step2_v11::!Shelf::FM::no_dupes::only_step2, #AK_Step2_v11::#OME_banner, #AK_Step2_v11::#Resources_by_rotation::FM::usptf_guidelines, #AK_Step2_v11::#Subjects::Obstetrics_&_Gynecology::01_Gynecology::Breast::Breast_Cancer, #AK_Step2_v11::#Subjects::Obstetrics_&_Gynecology::01_Gynecology::Breast::Breast_Cancer::Management, #AK_Step2_v11::Original_decks::Dorian::fam::usptf_guidelines
markdown: false

### Text
Women who are at <u>increased risk</u> for <b>breast cancer</b> and
<u>low risk</u> for <i>adverse medication effects</i> should
receive:
<div>
  {{c1::Tamoxifen <i>or</i> raloxifene}}
</div>

### Extra
antagonist at estrogen receptor at breast
<div><img src="paste-11171209936897_1490401575642.jpg"></div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid


### Sketchy


### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href="https://onlinemeded.org?ref=anki"><img src=
  "_OME_AnkiFlashcards_General_7.png"></a>
</div>

### Additional Resources


### One by one

